Glutamate signaling through the kainate receptor enhances human immunoglobulin production

Journal of Neuroimmunology

Volumn 233, Issue 1-2, 2011, Pages 80-89

  Sturgill, Jamie L ^a   Mathews, Joel ^a   Scherle, Peggy ^b   Conrad, Daniel H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

ADAM10; B cell; CD23; Glutamate; Immunoglobulin; Kainate receptor

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMPA RECEPTOR; CD23 ANTIGEN; CD40 ANTIGEN; GLUTAMIC ACID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 21; INTERLEUKIN 4; KAINIC ACID RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; B-LYMPHOCYTE SUBSETS; CELL LINE; GLUTAMIC ACID; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, IGE; RECEPTORS, KAINIC ACID; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79953301329     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.11.014     Document Type: Article

References (57)

1. Affaticati P., Mignen O., Jambou F., Potier M.C., Klingel-Schmitt I., Degrouard J., Peineau S., Gouadon E., Collingridge G.L., Liblau R., Capiod T., Cohen-Kaminsky S. Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells. Cell Death. Differ. 2011, 18 (1), 99-108 (Epub 2010 Jun 25).
2. Aitken K.J. Intersubjectivity, affective neuroscience, and the neurobiology of autistic spectrum disorders: a systematic review. Keio J. Med. 2008, 57:15-36.
3. Alstergren P., Ernberg M., Nilsson M., Hajati A.K., Sessle B.J., Kopp S. Glutamate-induced temporomandibular joint pain in healthy individuals is partially mediated by peripheral NMDA receptors. J. Orofac. Pain 2010, 24:172-180.
4. Atta A.M., Sousa C.P., Carvalho E.M., Sousa-Atta M.L. Immunoglobulin E and systemic lupus erythematosus. Braz. J. Med. Biol. Res. 2004, 37:1497-1501.
5. Bansal A., Roberts T., Hay E.M., Kay R., Pumphrey R.S., Wilson P.B. Soluble CD23 levels are elevated in the serum of patients with primary Sjogren's syndrome and systemic lupus erythematosus. Clin. Exp. Immunol. 1992, 89:452-455.
6. Bansal A.S., MacGregor A.J., Pumphrey R.S., Silman A.J., Ollier W.E., Wilson P.B. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin. Exp. Rheumatol. 1994, 12:281-285.
7. Boldyrev A.A., Kazey V.I., Leinsoo T.A., Mashkina A.P., Tyulina O.V., Johnson P., Tuneva J.O., Chittur S., Carpenter D.O. Rodent lymphocytes express functionally active glutamate receptors. Biochem. Biophys. Res. Commun. 2004, 324:133-139.
8. Boldyrev A.A., Carpenter D.O., Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J. Neurochem. 2005, 95:913-918.
9. Borsody M.K., Coco M.L. A hypothesis accounting for the inconsistent benefit of glucocorticoid therapy in closed head trauma. Med. Hypotheses 2001, 56:65-72.
10. Bowser C.S., Kaye J., Joks R.O., Charlot C.A., Moallem H.J. IgE and atopy in perinatally HIV-infected children. Pediatr. Allergy Immunol. 2007, 18:298-303.
11. Caven T.H., Shelburne A., Sato J., Chan-Li Y., Becker S., Conrad D.H. IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell. Immunol. 2005, 238:123-134.
12. Caven T.H., Shelburne A., Sato J., Chan-Li Y., Becker S., Conrad D.H. IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell. Immunol. 2005, 238:123-134.
13. Caven T.H., Sturgill J.L., Conrad D.H. BCR ligation antagonizes the IL-21 enhancement of anti-CD40/IL-4 plasma cell differentiation and IgE production found in low density human B cell cultures. Cell. Immunol. 2007, 247:49-58.
14. Chittajallu R., Braithwaite S.P., Clarke V.R., Henley J.M. Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol. Sci. 1999, 20:26-35.
15. Collingridge G.L., Olsen R.W., Peters J., Spedding M. A nomenclature for ligand-gated ion channels. Neuropharmacology 2009, 56:2-5.
16. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
17. Du Y., Li C., Hu W.W., Song Y.J., Zhang G.Y. Neuroprotection of preconditioning against ischemic brain injury in rat hippocampus through inhibition of the assembly of GluR6-PSD95-mixed lineage kinase 3 signaling module via nuclear and non-nuclear pathways. Neuroscience 2009, 161:370-380.
18. Eck H.P., Frey H., Droge W. Elevated plasma glutamate concentrations in HIV-1-infected patients may contribute to loss of macrophage and lymphocyte functions. Int. Immunol. 1989, 1:367-372.
19. Eck H.P., Betzler M., Schlag P., Droge W. Partial recovery of lymphocyte activity in patients with colorectal carcinoma after curative surgical treatment and return of plasma glutamate concentrations to normal levels. J. Cancer Res. Clin. Oncol. 1990, 116:648-650.
20. Engel T., Murphy B.M., Hatazaki S., Jimenez-Mateos E.M., Concannon C.G., Woods I., Prehn J.H., Henshall D.C. Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J. 2010, 24 (3), 853-861 (Epub 2009 Nov 4).
21. Flood S., Parri R., Williams A., Duance V., Mason D. Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors. Arthritis Rheum. 2007, 56:2523-2534.
22. Ford J.W., Kilmon M.A., Haas K.M., Shelburne A.E., Chan-Li Y., Conrad D.H. In vivo murine CD23 destabilization enhances CD23 shedding and IgE synthesis. Cell. Immunol. 2006, 243:107-117.
23. Frediani T., Lucarelli S., Pelliccia A., Vagnucci B., Cerminara C., Barbato M., Cardi E. Allergy and childhood epilepsy: a close relationship?. Acta Neurol. Scand. 2001, 104:349-352.
24. Fridman J.S., Caulder E., Hansbury M., Liu X., Yang G., Wang Q., Lo Y., Zhou B.B., Pan M., Thomas S.M., Grandis J.R., Zhuo J., Yao W., Newton R.C., Friedman S.M., Scherle P.A., Vaddi K. Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 2007, 13:1892-1902.
25. Ganor Y., Besser M., Ben-Zakay N., Unger T., Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J. Immunol. 2003, 170:4362-4372.
26. Ganor Y., Besser M., Ben-Zakay N., Unger T., Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J. Immunol. 2003, 170:4362-4372.
27. Gupta Y.K., Briyal S., Sharma M. Protective effect of curcumin against kainic acid induced seizures and oxidative stress in rats. Indian J. Physiol. Pharmacol. 2009, 53:39-46.
28. Haas H.S., Pfragner R., Siegl V., Ingolic E., Heintz E., Schauenstein K. Glutamate receptor-mediated effects on growth and morphology of human histiocytic lymphoma cells. Int. J. Oncol. 2005, 27:867-874.
29. Hasbold J., Lyons A.B., Kehry M.R., Hodgkin P.D. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol. 1998, 28:1040-1051.
30. Hou Y.Y., Liu Y., Kang S., Yu C., Chi Z.Q., Liu J.G. Glutamate receptors in the dorsal hippocampus mediate the acquisition, but not the expression, of conditioned place aversion induced by acute morphine withdrawal in rats. Acta Pharmacol. Sin. 2009, 30:1385-1391.
31. Lecoanet-Henchoz S., Gauchat J.-F., Aubry J.-P., Graber P., Life P., Paul Eugene N., Ferrua B., Corbi A.L., Dugas B., Plater-Zyberk C., Bonnefoy J.-Y. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Imm 1995, 3:119-125.
32. Lerma J. Kainate receptor physiology. Curr. Opin. Pharmacol. 2006, 6:89-97.
33. Lerma J., Paternain A.V., Rodriguez-Moreno A., Lopez-Garcia J.C. Molecular physiology of kainate receptors. Physiol. Rev. 2001, 81:971-998.
34. Lyoo I.K., Yoon S.J., Musen G., Simonson D.C., Weinger K., Bolo N., Ryan C.M., Kim J.E., Renshaw P.F., Jacobson A.M. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch. Gen. Psychiatry 2009, 66:878-887.
35. McNearney T., Speegle D., Lawand N., Lisse J., Westlund K.N. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J. Rheumatol. 2000, 27:739-745.
36. Mulle C., Sailer A., Perez-Otano I., ckinson-Anson H., Castillo P.E., Bureau I., Maron C., Gage F.H., Mann J.R., Bettler B., Heinemann S.F. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 1998, 392:601-605.
37. Nance D.M., Sanders V.M. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav. Immun. 2007, 21:736-745.
38. Oprica M., Spulber S.D., Aronsson A.F., Post C., Winblad B., Schultzberg M. The influence of kainic acid on core temperature and cytokine levels in the brain. Cytokine 2006, 35:77-87.
39. Ortiz R.M., Karkkainen I., Huovila A.P., Honkaniemi J. ADAM9, ADAM10, and ADAM15 mRNA levels in the rat brain after kainic acid-induced status epilepticus. Brain Res. Mol. Brain Res. 2005, 137:272-275.
40. Pacheco R., Riquelme E., Kalergis A.M. Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands. Cent. Nerv. Syst. Agents Med. Chem. 2010, 10:65-83.
41. Payet-Jamroz M., Helm S.L., Wu J., Kilmon M., Fakher M., Basalp A., Tew J.G., Szakal A.K., Noben-Trauth N., Conrad D.H. Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells. J. Immunol. 2001, 166:4863-4869.
42. Rabah, D., Conrad, D.H., 2002. Effect of Cell Density on in vitro mouse IgE production. Immunology 106 (4), 503-510.
43. Raber J. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits. Mol. Neurobiol. 1998, 18:1-22.
44. Rainesalo S., Keranen T., Palmio J., Peltola J., Oja S.S., Saransaari P. Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem. Res. 2004, 29:319-324.
45. Ramsdell J.S., Stafstrom C.E. Rat kainic Acid model provides unexpected insight into an emerging epilepsy syndrome in sea lions. Epilepsy Curr. 2009, 9:142-143.
46. Rawls S.M., Thomas T., Adeola M., Patil T., Raymondi N., Poles A., Loo M., Raffa R.B. Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol. Biochem. Behav. 2009, 93:363-367.
47. Saxon A., Ke Z., Bahati L., Stevens R.H. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. J. Allergy Clin. Immunol. 1990, 86:333-344.
48. Sun H., Swaim A., Herrera J.E., Becker D., Becker L., Srivastava K., Thompson L.E., Shero M.R., Perez-Tamayo A., Suktitipat B., Mathias R., Contractor A., Faraday N., Morrell C.N. Platelet kainate receptor signaling promotes thrombosis by stimulating cyclooxygenase activation. Circ. Res. 2009, 105:595-603.
49. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 2002, 22:920-930.
50. Texido G., Eibel H., Le Gros G., Van der Putten H. Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses. J. Immunol. 1994, 153:3028-3042.
51. Verdoorn T.A., Johansen T.H., Drejer J., Nielsen E.O. Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur. J. Pharmacol. 1994, 269:43-49.
52. Weskamp G., Ford J.W., Sturgill J., Martin S., Docherty A.J., Swendeman S., Broadway N., Hartmann D., Saftig P., Umland S., Sehara-Fujisawa A., Black R.A., Ludwig A., Becherer J.D., Conrad D.H., Blobel C.P. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat. Immunol. 2006, 7:1293-1298.
53. West S.G. The nervous system. Dubois' Lupus Erythematosus 2007, 707-747. Lippincott Wiliams and Wilkins, Philadelphia. D.J. Wallace, B. Hahn, E.L. Dubois (Eds.).
54. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J. Neuroimmunol. 2006, 172:38-58.
55. Yu P., Kosco-Vilbois M., Richards M., Köhler G., Lamers M.C., Kohler G. Negative feedback regulation of IgE synthesis by murine CD23. Nature 1994, 369:753-756.
56. Zemlyak I., Manley N., Vulih-Shultzman I., Cutler A.B., Graber K., Sapolsky R.M., Gozes I. The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy. J. Neurochem. 2009, 111:1252-1263.
57. Zhou B.B., Peyton M., He B., Liu C., Girard L., Caudler E., Lo Y., Baribaud F., Mikami I., Reguart N., Yang G., Li Y., Yao W., Vaddi K., Gazdar A.F., Friedman S.M., Jablons D.M., Newton R.C., Fridman J.S., Minna J.D., Scherle P.A. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 2006, 10:39-50.